跳至主要内容
临床试验/IRCT20231219060463N1
IRCT20231219060463N1尚未招募3 期

Comparison of the effectiveness of Azathioprine and placebo on lung volumes, exacerbations and severity of asthma in severe asthmatic patients

Ahvaz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Severe asthmatic patients (FEV1<60) diagnosed by pulmonologist
  • No improvement in symptoms with usual treatments for asthma including Prednisolone 5mg/day, High dose inhaled corticosteroid, Long acting beta agonist and Long acting muscarinic antagonist

排除标准

  • Advanced liver failure
  • Advanced renal failure
  • Breastfeeding
  • Moderate to severe anemia
  • Known allergy to azathioprine
  • Concomitant treatment with: Allopurinol, Febuxostat, Adalimumab, Anakinra
  • Elevated liver enzymes (aminasemia)

研究者

相似试验